Stocks were indicated higher on Wednesday after Tuesday’s substantial rally. Yet again, investors have bought the dips, even if this dip was over 10% from peak to trough. 24/7 Wall St. reviews dozens of analyst research reports each day to find new trading and investing ideas for its readers. Some analyst calls cover stocks to buy, while other calls cover stocks to sell or avoid.

These are this Wednesday’s top analyst upgrades, downgrades and initiations.

Celgene Corp. (NASDAQ: CELG) was started as Buy with a $140.00 price target (versus a $117.39 prior close) at Jefferies. Celgene rose almost 5% on Tuesday and was indicated up 1.2% at $124.50 on Wednesday. It has a consensus price target of almost $150.00 and a 52-week trading range of $83.16 to $140.72.

Ciena Corp. (NASDAQ: CIEN) was raised to Outperform from Market Perform at RBC Capital Markets. Ciena’s price target is $28.00, versus a $22.94 close and a consensus price target of $27.85. The 52-week range is $13.77 to $26.50.

Goldman Sachs Group Inc. (NYSE: GS) was raised to Buy from Neutral at Bank of America Merrill Lynch. Goldman Sachs closed up 3% at $185.88, was indicated up another 2% to $189.60 in early Wednesday trading and it has a 52-week range of $171.26 to $218.77.

MannKind Corp. (NASDAQ: MNKD) was downgraded to Underweight from Neutral and the price target was slashed to $1.50 from $4.00 at Piper Jaffray. MannKind closed at $4.07 on Tuesday, and shares were indicated lower by 7% at $3.77 on Wednesday. The consensus price target close to $6.50 before the call, and the 52-week trading range is $3.25 to $7.88. This is after last week’s share sale agreement.

Newfield Exploration Co. (NYSE: NFX) was started as Outperform with a $45.00 price target (versus a $34.14 close) at Credit Suisse. Newfield has a consensus price target of $43.04 and has a 52-week range of $22.31 to $40.27.

Tetraphase Pharmaceuticals Inc. (NASDAQ: TTPH) was downgraded to Neutral from Outperform at Wedbush Securities. It also was downgraded to Hold from Buy at Stifel Nicolaus, Needham and Canaccord Genuity. Tetraphase announced that eravacycline did not meet its primary endpoint in pivotal portion of a trial, and shares are indicated down almost 80% and close to $9.00, after a $44.78 close and with a prior 52-week range of $15.68 to $52.90.

UnitedHealth Group Inc. (NYSE: UNH) was started as Overweight with a $140.00 price target (versus a $116.09 close) at Morgan Stanley. The consensus analyst price target is $147.32, and the 52-week range is $80.72 to $126.21.

ALSO READ: 4 Top Jefferies Growth Stock Picks to Buy Now

Walgreens Boots Alliance Inc. (NASDAQ: WBA) was raised to Outperform from Market Perform and the price target was raised to $104.00 from $90.00 (versus $90.09 close) at Cowen.

Yingli Green Energy Holding Co. Ltd. (NYSE: YGE) was downgraded to Sell from Neutral with a $0.50 price target (versus a $0.58 close) at Roth Capital. Yingli has a 52-week range of $0.55 to $3.89, and that 52-week low was just hit on Tuesday.

Additional analyst upgrades, downgrades and initiations this Wednesday were seen as follows:

Boston Properties Inc. (NYSE: BXP) was raised to Buy from Hold at Stifel Nicolaus.

Domino’s Pizza Inc. (NYSE: DPZ) was raised to Buy from Neutral with a price target of $122.00 (versus a $109.00 close) at Goldman Sachs.

EnLink Midstream LLC (NYSE: ENLC) was raised to Buy from Neutral at UBS.

Equinix Inc. (NASDAQ: EQIX) was reiterated as Buy with a $315.00 price target (versus a $279.28 close) at Canaccord Genuity. This call was based on Equinix’s acquisition of Bit-isle bolstering its presence in Japan.

Equity Commonwealth (NYSE: EQC) was raised to Neutral from Underperform with a $31.00 price target (versus a $25.56 close) at Merrill Lynch.

Franklin Resources Inc. (NYSE: BEN) was raised to Buy from Hold with a $46.00 price target (versus a $40.07 close) at Deutsche Bank.

ALSO READ: Warren Buffett Clarifies Buying More IBM and Phillips 66 Shares

NXP Semiconductors N.V. (NASDAQ: NXPI) was started as Buy with a $113.00 price target (versus a $90.68 close, after a 7.4% gain) at Sterne Agee. This is just a day after was NXP was reiterated as Buy with a $130.00 price target (versus an $84.43 close and a $120 consensus target) at Canaccord Genuity.

Pacific Sunwear of California Inc. (NASDAQ: PSUN) was downgraded to Hold from Buy and the price target was cut to $1.65 from $4.50 (versus a $0.60 close) at Topeka Capital Markets.

Prologis Inc. (NYSE: PLD) was raised to Buy from Hold and the $41.00 price target was maintained at Stifel Nicolaus.

SL Green Realty Corp. (NYSE: SLG) was raised to Buy from Hold at Stifel Nicolaus.

TG Therapeutics Inc. (NASDAQ: TGTX) was started as Strong Buy with a $20.00 price target (versus an $11.45 close) at Raymond James.

Investors should take note that Merrill Lynch lowered its 2015 price target on the S&P 500 to 2,100 from 2,200 on Tuesday, and Morgan Stanley lowered its price target to 2,200 from 2,275.

If you missed out on Tuesday’s top analyst upgrades and downgrades, they were in shares of Amgen, Dow Chemical, Fitbit, Office Depot, SanDisk, Wells Fargo, Yum! Brands and over a dozen more companies.

ALSO READ: Merrill Lynch Makes Key Ratings Change in Metals Leaders

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.